Medical Devices & Consumables
Global Androgen Deprivation Therapy (ADT) Market Insights, Forecast to 2030
- Mar 07, 25
- ID: 2874
- Pages: 109
- Figures: 134
- Views: 94
Androgen Deprivation Therapy is an antihormone therapy whose main use is in treating prostate cancer.
Market Analysis and Insights: Global Androgen Deprivation Therapy (ADT) Market
The global Androgen Deprivation Therapy (ADT) market is projected to grow from US$ 6245.6 million in 2024 to US$ 8369.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.0% during the forecast period.
The US & Canada market for Androgen Deprivation Therapy (ADT) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Androgen Deprivation Therapy (ADT) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Androgen Deprivation Therapy (ADT) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Androgen Deprivation Therapy (ADT) include Pfizer, Astellas Pharma, Johnson & Johnson, Novartis International, Merck, Veru, Sanofi, GlaxoSmithKline and Bayer, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Androgen Deprivation Therapy (ADT) is widely used in various fields, such as Hospital, Clinic and Other,, etc. Hospital provides greatest supports to the Androgen Deprivation Therapy (ADT) industry development. In 2023, global % revenue of Androgen Deprivation Therapy (ADT) went into Hospital filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Androgen Deprivation Therapy (ADT) market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Androgen Deprivation Therapy (ADT), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Androgen Deprivation Therapy (ADT), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Androgen Deprivation Therapy (ADT) revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Androgen Deprivation Therapy (ADT) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Androgen Deprivation Therapy (ADT) revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Pfizer
Astellas Pharma
Johnson & Johnson
Novartis International
Merck
Veru
Sanofi
GlaxoSmithKline
Bayer
Orion
AstraZeneca
Segment by Type
Medicine
Surgery
Other
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Androgen Deprivation Therapy (ADT) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Androgen Deprivation Therapy (ADT) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Androgen Deprivation Therapy (ADT) revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Market Analysis and Insights: Global Androgen Deprivation Therapy (ADT) Market
The global Androgen Deprivation Therapy (ADT) market is projected to grow from US$ 6245.6 million in 2024 to US$ 8369.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.0% during the forecast period.
The US & Canada market for Androgen Deprivation Therapy (ADT) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Androgen Deprivation Therapy (ADT) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Androgen Deprivation Therapy (ADT) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Androgen Deprivation Therapy (ADT) include Pfizer, Astellas Pharma, Johnson & Johnson, Novartis International, Merck, Veru, Sanofi, GlaxoSmithKline and Bayer, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Androgen Deprivation Therapy (ADT) is widely used in various fields, such as Hospital, Clinic and Other,, etc. Hospital provides greatest supports to the Androgen Deprivation Therapy (ADT) industry development. In 2023, global % revenue of Androgen Deprivation Therapy (ADT) went into Hospital filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Androgen Deprivation Therapy (ADT) market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Androgen Deprivation Therapy (ADT), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Androgen Deprivation Therapy (ADT), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Androgen Deprivation Therapy (ADT) revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Androgen Deprivation Therapy (ADT) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Androgen Deprivation Therapy (ADT) revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Pfizer
Astellas Pharma
Johnson & Johnson
Novartis International
Merck
Veru
Sanofi
GlaxoSmithKline
Bayer
Orion
AstraZeneca
Segment by Type
Medicine
Surgery
Other
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Androgen Deprivation Therapy (ADT) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Androgen Deprivation Therapy (ADT) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Androgen Deprivation Therapy (ADT) revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Medicine
1.2.3 Surgery
1.2.4 Other
1.3 Market by Application
1.3.1 Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Androgen Deprivation Therapy (ADT) Market Perspective (2019-2030)
2.2 Global Androgen Deprivation Therapy (ADT) Growth Trends by Region
2.2.1 Androgen Deprivation Therapy (ADT) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Androgen Deprivation Therapy (ADT) Historic Market Size by Region (2019-2024)
2.2.3 Androgen Deprivation Therapy (ADT) Forecasted Market Size by Region (2025-2030)
2.3 Androgen Deprivation Therapy (ADT) Market Dynamics
2.3.1 Androgen Deprivation Therapy (ADT) Industry Trends
2.3.2 Androgen Deprivation Therapy (ADT) Market Drivers
2.3.3 Androgen Deprivation Therapy (ADT) Market Challenges
2.3.4 Androgen Deprivation Therapy (ADT) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Androgen Deprivation Therapy (ADT) by Players
3.1.1 Global Androgen Deprivation Therapy (ADT) Revenue by Players (2019-2024)
3.1.2 Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Players (2019-2024)
3.2 Global Androgen Deprivation Therapy (ADT) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Androgen Deprivation Therapy (ADT), Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Androgen Deprivation Therapy (ADT) Market Concentration Ratio
3.4.1 Global Androgen Deprivation Therapy (ADT) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Androgen Deprivation Therapy (ADT) Revenue in 2023
3.5 Global Key Players of Androgen Deprivation Therapy (ADT) Head office and Area Served
3.6 Global Key Players of Androgen Deprivation Therapy (ADT), Product and Application
3.7 Global Key Players of Androgen Deprivation Therapy (ADT), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Androgen Deprivation Therapy (ADT) Breakdown Data by Type
4.1 Global Androgen Deprivation Therapy (ADT) Historic Market Size by Type (2019-2024)
4.2 Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Type (2025-2030)
5 Androgen Deprivation Therapy (ADT) Breakdown Data by Application
5.1 Global Androgen Deprivation Therapy (ADT) Historic Market Size by Application (2019-2024)
5.2 Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Androgen Deprivation Therapy (ADT) Market Size (2019-2030)
6.2 North America Androgen Deprivation Therapy (ADT) Market Size by Type
6.2.1 North America Androgen Deprivation Therapy (ADT) Market Size by Type (2019-2024)
6.2.2 North America Androgen Deprivation Therapy (ADT) Market Size by Type (2025-2030)
6.2.3 North America Androgen Deprivation Therapy (ADT) Market Share by Type (2019-2030)
6.3 North America Androgen Deprivation Therapy (ADT) Market Size by Application
6.3.1 North America Androgen Deprivation Therapy (ADT) Market Size by Application (2019-2024)
6.3.2 North America Androgen Deprivation Therapy (ADT) Market Size by Application (2025-2030)
6.3.3 North America Androgen Deprivation Therapy (ADT) Market Share by Application (2019-2030)
6.4 North America Androgen Deprivation Therapy (ADT) Market Size by Country
6.4.1 North America Androgen Deprivation Therapy (ADT) Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Androgen Deprivation Therapy (ADT) Market Size by Country (2019-2024)
6.4.3 North America Androgen Deprivation Therapy (ADT) Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Androgen Deprivation Therapy (ADT) Market Size (2019-2030)
7.2 Europe Androgen Deprivation Therapy (ADT) Market Size by Type
7.2.1 Europe Androgen Deprivation Therapy (ADT) Market Size by Type (2019-2024)
7.2.2 Europe Androgen Deprivation Therapy (ADT) Market Size by Type (2025-2030)
7.2.3 Europe Androgen Deprivation Therapy (ADT) Market Share by Type (2019-2030)
7.3 Europe Androgen Deprivation Therapy (ADT) Market Size by Application
7.3.1 Europe Androgen Deprivation Therapy (ADT) Market Size by Application (2019-2024)
7.3.2 Europe Androgen Deprivation Therapy (ADT) Market Size by Application (2025-2030)
7.3.3 Europe Androgen Deprivation Therapy (ADT) Market Share by Application (2019-2030)
7.4 Europe Androgen Deprivation Therapy (ADT) Market Size by Country
7.4.1 Europe Androgen Deprivation Therapy (ADT) Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2019-2024)
7.4.3 Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Androgen Deprivation Therapy (ADT) Market Size (2019-2030)
8.2 China Androgen Deprivation Therapy (ADT) Market Size by Type
8.2.1 China Androgen Deprivation Therapy (ADT) Market Size by Type (2019-2024)
8.2.2 China Androgen Deprivation Therapy (ADT) Market Size by Type (2025-2030)
8.2.3 China Androgen Deprivation Therapy (ADT) Market Share by Type (2019-2030)
8.3 China Androgen Deprivation Therapy (ADT) Market Size by Application
8.3.1 China Androgen Deprivation Therapy (ADT) Market Size by Application (2019-2024)
8.3.2 China Androgen Deprivation Therapy (ADT) Market Size by Application (2025-2030)
8.3.3 China Androgen Deprivation Therapy (ADT) Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Androgen Deprivation Therapy (ADT) Market Size (2019-2030)
9.2 Asia Androgen Deprivation Therapy (ADT) Market Size by Type
9.2.1 Asia Androgen Deprivation Therapy (ADT) Market Size by Type (2019-2024)
9.2.2 Asia Androgen Deprivation Therapy (ADT) Market Size by Type (2025-2030)
9.2.3 Asia Androgen Deprivation Therapy (ADT) Market Share by Type (2019-2030)
9.3 Asia Androgen Deprivation Therapy (ADT) Market Size by Application
9.3.1 Asia Androgen Deprivation Therapy (ADT) Market Size by Application (2019-2024)
9.3.2 Asia Androgen Deprivation Therapy (ADT) Market Size by Application (2025-2030)
9.3.3 Asia Androgen Deprivation Therapy (ADT) Market Share by Application (2019-2030)
9.4 Asia Androgen Deprivation Therapy (ADT) Market Size by Region
9.4.1 Asia Androgen Deprivation Therapy (ADT) Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Androgen Deprivation Therapy (ADT) Market Size by Region (2019-2024)
9.4.3 Asia Androgen Deprivation Therapy (ADT) Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Size by Type
10.2.1 Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Size by Application
10.3.1 Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Size by Country
10.4.1 Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Androgen Deprivation Therapy (ADT) Introduction
11.1.4 Pfizer Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)
11.1.5 Pfizer Recent Developments
11.2 Astellas Pharma
11.2.1 Astellas Pharma Company Details
11.2.2 Astellas Pharma Business Overview
11.2.3 Astellas Pharma Androgen Deprivation Therapy (ADT) Introduction
11.2.4 Astellas Pharma Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)
11.2.5 Astellas Pharma Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Androgen Deprivation Therapy (ADT) Introduction
11.3.4 Johnson & Johnson Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)
11.3.5 Johnson & Johnson Recent Developments
11.4 Novartis International
11.4.1 Novartis International Company Details
11.4.2 Novartis International Business Overview
11.4.3 Novartis International Androgen Deprivation Therapy (ADT) Introduction
11.4.4 Novartis International Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)
11.4.5 Novartis International Recent Developments
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Androgen Deprivation Therapy (ADT) Introduction
11.5.4 Merck Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)
11.5.5 Merck Recent Developments
11.6 Veru
11.6.1 Veru Company Details
11.6.2 Veru Business Overview
11.6.3 Veru Androgen Deprivation Therapy (ADT) Introduction
11.6.4 Veru Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)
11.6.5 Veru Recent Developments
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Androgen Deprivation Therapy (ADT) Introduction
11.7.4 Sanofi Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)
11.7.5 Sanofi Recent Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Androgen Deprivation Therapy (ADT) Introduction
11.8.4 GlaxoSmithKline Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)
11.8.5 GlaxoSmithKline Recent Developments
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Androgen Deprivation Therapy (ADT) Introduction
11.9.4 Bayer Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)
11.9.5 Bayer Recent Developments
11.10 Orion
11.10.1 Orion Company Details
11.10.2 Orion Business Overview
11.10.3 Orion Androgen Deprivation Therapy (ADT) Introduction
11.10.4 Orion Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)
11.10.5 Orion Recent Developments
11.11 AstraZeneca
11.11.1 AstraZeneca Company Details
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Androgen Deprivation Therapy (ADT) Introduction
11.11.4 AstraZeneca Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)
11.11.5 AstraZeneca Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Medicine
1.2.3 Surgery
1.2.4 Other
1.3 Market by Application
1.3.1 Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Androgen Deprivation Therapy (ADT) Market Perspective (2019-2030)
2.2 Global Androgen Deprivation Therapy (ADT) Growth Trends by Region
2.2.1 Androgen Deprivation Therapy (ADT) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Androgen Deprivation Therapy (ADT) Historic Market Size by Region (2019-2024)
2.2.3 Androgen Deprivation Therapy (ADT) Forecasted Market Size by Region (2025-2030)
2.3 Androgen Deprivation Therapy (ADT) Market Dynamics
2.3.1 Androgen Deprivation Therapy (ADT) Industry Trends
2.3.2 Androgen Deprivation Therapy (ADT) Market Drivers
2.3.3 Androgen Deprivation Therapy (ADT) Market Challenges
2.3.4 Androgen Deprivation Therapy (ADT) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Androgen Deprivation Therapy (ADT) by Players
3.1.1 Global Androgen Deprivation Therapy (ADT) Revenue by Players (2019-2024)
3.1.2 Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Players (2019-2024)
3.2 Global Androgen Deprivation Therapy (ADT) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Androgen Deprivation Therapy (ADT), Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Androgen Deprivation Therapy (ADT) Market Concentration Ratio
3.4.1 Global Androgen Deprivation Therapy (ADT) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Androgen Deprivation Therapy (ADT) Revenue in 2023
3.5 Global Key Players of Androgen Deprivation Therapy (ADT) Head office and Area Served
3.6 Global Key Players of Androgen Deprivation Therapy (ADT), Product and Application
3.7 Global Key Players of Androgen Deprivation Therapy (ADT), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Androgen Deprivation Therapy (ADT) Breakdown Data by Type
4.1 Global Androgen Deprivation Therapy (ADT) Historic Market Size by Type (2019-2024)
4.2 Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Type (2025-2030)
5 Androgen Deprivation Therapy (ADT) Breakdown Data by Application
5.1 Global Androgen Deprivation Therapy (ADT) Historic Market Size by Application (2019-2024)
5.2 Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Androgen Deprivation Therapy (ADT) Market Size (2019-2030)
6.2 North America Androgen Deprivation Therapy (ADT) Market Size by Type
6.2.1 North America Androgen Deprivation Therapy (ADT) Market Size by Type (2019-2024)
6.2.2 North America Androgen Deprivation Therapy (ADT) Market Size by Type (2025-2030)
6.2.3 North America Androgen Deprivation Therapy (ADT) Market Share by Type (2019-2030)
6.3 North America Androgen Deprivation Therapy (ADT) Market Size by Application
6.3.1 North America Androgen Deprivation Therapy (ADT) Market Size by Application (2019-2024)
6.3.2 North America Androgen Deprivation Therapy (ADT) Market Size by Application (2025-2030)
6.3.3 North America Androgen Deprivation Therapy (ADT) Market Share by Application (2019-2030)
6.4 North America Androgen Deprivation Therapy (ADT) Market Size by Country
6.4.1 North America Androgen Deprivation Therapy (ADT) Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Androgen Deprivation Therapy (ADT) Market Size by Country (2019-2024)
6.4.3 North America Androgen Deprivation Therapy (ADT) Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Androgen Deprivation Therapy (ADT) Market Size (2019-2030)
7.2 Europe Androgen Deprivation Therapy (ADT) Market Size by Type
7.2.1 Europe Androgen Deprivation Therapy (ADT) Market Size by Type (2019-2024)
7.2.2 Europe Androgen Deprivation Therapy (ADT) Market Size by Type (2025-2030)
7.2.3 Europe Androgen Deprivation Therapy (ADT) Market Share by Type (2019-2030)
7.3 Europe Androgen Deprivation Therapy (ADT) Market Size by Application
7.3.1 Europe Androgen Deprivation Therapy (ADT) Market Size by Application (2019-2024)
7.3.2 Europe Androgen Deprivation Therapy (ADT) Market Size by Application (2025-2030)
7.3.3 Europe Androgen Deprivation Therapy (ADT) Market Share by Application (2019-2030)
7.4 Europe Androgen Deprivation Therapy (ADT) Market Size by Country
7.4.1 Europe Androgen Deprivation Therapy (ADT) Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2019-2024)
7.4.3 Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Androgen Deprivation Therapy (ADT) Market Size (2019-2030)
8.2 China Androgen Deprivation Therapy (ADT) Market Size by Type
8.2.1 China Androgen Deprivation Therapy (ADT) Market Size by Type (2019-2024)
8.2.2 China Androgen Deprivation Therapy (ADT) Market Size by Type (2025-2030)
8.2.3 China Androgen Deprivation Therapy (ADT) Market Share by Type (2019-2030)
8.3 China Androgen Deprivation Therapy (ADT) Market Size by Application
8.3.1 China Androgen Deprivation Therapy (ADT) Market Size by Application (2019-2024)
8.3.2 China Androgen Deprivation Therapy (ADT) Market Size by Application (2025-2030)
8.3.3 China Androgen Deprivation Therapy (ADT) Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Androgen Deprivation Therapy (ADT) Market Size (2019-2030)
9.2 Asia Androgen Deprivation Therapy (ADT) Market Size by Type
9.2.1 Asia Androgen Deprivation Therapy (ADT) Market Size by Type (2019-2024)
9.2.2 Asia Androgen Deprivation Therapy (ADT) Market Size by Type (2025-2030)
9.2.3 Asia Androgen Deprivation Therapy (ADT) Market Share by Type (2019-2030)
9.3 Asia Androgen Deprivation Therapy (ADT) Market Size by Application
9.3.1 Asia Androgen Deprivation Therapy (ADT) Market Size by Application (2019-2024)
9.3.2 Asia Androgen Deprivation Therapy (ADT) Market Size by Application (2025-2030)
9.3.3 Asia Androgen Deprivation Therapy (ADT) Market Share by Application (2019-2030)
9.4 Asia Androgen Deprivation Therapy (ADT) Market Size by Region
9.4.1 Asia Androgen Deprivation Therapy (ADT) Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Androgen Deprivation Therapy (ADT) Market Size by Region (2019-2024)
9.4.3 Asia Androgen Deprivation Therapy (ADT) Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Size by Type
10.2.1 Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Size by Application
10.3.1 Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Size by Country
10.4.1 Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Androgen Deprivation Therapy (ADT) Introduction
11.1.4 Pfizer Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)
11.1.5 Pfizer Recent Developments
11.2 Astellas Pharma
11.2.1 Astellas Pharma Company Details
11.2.2 Astellas Pharma Business Overview
11.2.3 Astellas Pharma Androgen Deprivation Therapy (ADT) Introduction
11.2.4 Astellas Pharma Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)
11.2.5 Astellas Pharma Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Androgen Deprivation Therapy (ADT) Introduction
11.3.4 Johnson & Johnson Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)
11.3.5 Johnson & Johnson Recent Developments
11.4 Novartis International
11.4.1 Novartis International Company Details
11.4.2 Novartis International Business Overview
11.4.3 Novartis International Androgen Deprivation Therapy (ADT) Introduction
11.4.4 Novartis International Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)
11.4.5 Novartis International Recent Developments
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Androgen Deprivation Therapy (ADT) Introduction
11.5.4 Merck Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)
11.5.5 Merck Recent Developments
11.6 Veru
11.6.1 Veru Company Details
11.6.2 Veru Business Overview
11.6.3 Veru Androgen Deprivation Therapy (ADT) Introduction
11.6.4 Veru Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)
11.6.5 Veru Recent Developments
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Androgen Deprivation Therapy (ADT) Introduction
11.7.4 Sanofi Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)
11.7.5 Sanofi Recent Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Androgen Deprivation Therapy (ADT) Introduction
11.8.4 GlaxoSmithKline Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)
11.8.5 GlaxoSmithKline Recent Developments
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Androgen Deprivation Therapy (ADT) Introduction
11.9.4 Bayer Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)
11.9.5 Bayer Recent Developments
11.10 Orion
11.10.1 Orion Company Details
11.10.2 Orion Business Overview
11.10.3 Orion Androgen Deprivation Therapy (ADT) Introduction
11.10.4 Orion Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)
11.10.5 Orion Recent Developments
11.11 AstraZeneca
11.11.1 AstraZeneca Company Details
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Androgen Deprivation Therapy (ADT) Introduction
11.11.4 AstraZeneca Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)
11.11.5 AstraZeneca Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Medicine
Table 3. Key Players of Surgery
Table 4. Key Players of Other
Table 5. Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Androgen Deprivation Therapy (ADT) Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Androgen Deprivation Therapy (ADT) Market Share by Region (2019-2024)
Table 9. Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Androgen Deprivation Therapy (ADT) Market Share by Region (2025-2030)
Table 11. Androgen Deprivation Therapy (ADT) Market Trends
Table 12. Androgen Deprivation Therapy (ADT) Market Drivers
Table 13. Androgen Deprivation Therapy (ADT) Market Challenges
Table 14. Androgen Deprivation Therapy (ADT) Market Restraints
Table 15. Global Androgen Deprivation Therapy (ADT) Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Androgen Deprivation Therapy (ADT) Revenue Share by Players (2019-2024)
Table 17. Global Top Androgen Deprivation Therapy (ADT) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Androgen Deprivation Therapy (ADT) as of 2023)
Table 18. Global Androgen Deprivation Therapy (ADT) Industry Ranking 2022 VS 2023 VS 2024
Table 19. Global 5 Largest Players Market Share by Androgen Deprivation Therapy (ADT) Revenue (CR5 and HHI) & (2019-2024)
Table 20. Global Key Players of Androgen Deprivation Therapy (ADT), Headquarters and Area Served
Table 21. Global Key Players of Androgen Deprivation Therapy (ADT), Product and Application
Table 22. Global Key Players of Androgen Deprivation Therapy (ADT), Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Androgen Deprivation Therapy (ADT) Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Type (2019-2024)
Table 26. Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Type (2025-2030)
Table 28. Global Androgen Deprivation Therapy (ADT) Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Androgen Deprivation Therapy (ADT) Revenue Share by Application (2019-2024)
Table 30. Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Androgen Deprivation Therapy (ADT) Revenue Share by Application (2025-2030)
Table 32. North America Androgen Deprivation Therapy (ADT) Market Size by Type (2019-2024) & (US$ Million)
Table 33. North America Androgen Deprivation Therapy (ADT) Market Size by Type (2025-2030) & (US$ Million)
Table 34. North America Androgen Deprivation Therapy (ADT) Market Size by Application (2019-2024) & (US$ Million)
Table 35. North America Androgen Deprivation Therapy (ADT) Market Size by Application (2025-2030) & (US$ Million)
Table 36. North America Androgen Deprivation Therapy (ADT) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Androgen Deprivation Therapy (ADT) Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Androgen Deprivation Therapy (ADT) Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Androgen Deprivation Therapy (ADT) Market Size by Type (2019-2024) & (US$ Million)
Table 40. Europe Androgen Deprivation Therapy (ADT) Market Size by Type (2025-2030) & (US$ Million)
Table 41. Europe Androgen Deprivation Therapy (ADT) Market Size by Application (2019-2024) & (US$ Million)
Table 42. Europe Androgen Deprivation Therapy (ADT) Market Size by Application (2025-2030) & (US$ Million)
Table 43. Europe Androgen Deprivation Therapy (ADT) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2019-2024) & (US$ Million)
Table 45. Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2025-2030) & (US$ Million)
Table 46. China Androgen Deprivation Therapy (ADT) Market Size by Type (2019-2024) & (US$ Million)
Table 47. China Androgen Deprivation Therapy (ADT) Market Size by Type (2025-2030) & (US$ Million)
Table 48. China Androgen Deprivation Therapy (ADT) Market Size by Application (2019-2024) & (US$ Million)
Table 49. China Androgen Deprivation Therapy (ADT) Market Size by Application (2025-2030) & (US$ Million)
Table 50. Asia Androgen Deprivation Therapy (ADT) Market Size by Type (2019-2024) & (US$ Million)
Table 51. Asia Androgen Deprivation Therapy (ADT) Market Size by Type (2025-2030) & (US$ Million)
Table 52. Asia Androgen Deprivation Therapy (ADT) Market Size by Application (2019-2024) & (US$ Million)
Table 53. Asia Androgen Deprivation Therapy (ADT) Market Size by Application (2025-2030) & (US$ Million)
Table 54. Asia Androgen Deprivation Therapy (ADT) Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 55. Asia Androgen Deprivation Therapy (ADT) Market Size by Region (2019-2024) & (US$ Million)
Table 56. Asia Androgen Deprivation Therapy (ADT) Market Size by Region (2025-2030) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Size by Type (2019-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Size by Type (2025-2030) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Size by Application (2019-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Size by Application (2025-2030) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 62. Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2019-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2025-2030) & (US$ Million)
Table 64. Pfizer Company Details
Table 65. Pfizer Business Overview
Table 66. Pfizer Androgen Deprivation Therapy (ADT) Product
Table 67. Pfizer Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)
Table 68. Pfizer Recent Developments
Table 69. Astellas Pharma Company Details
Table 70. Astellas Pharma Business Overview
Table 71. Astellas Pharma Androgen Deprivation Therapy (ADT) Product
Table 72. Astellas Pharma Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)
Table 73. Astellas Pharma Recent Developments
Table 74. Johnson & Johnson Company Details
Table 75. Johnson & Johnson Business Overview
Table 76. Johnson & Johnson Androgen Deprivation Therapy (ADT) Product
Table 77. Johnson & Johnson Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)
Table 78. Johnson & Johnson Recent Developments
Table 79. Novartis International Company Details
Table 80. Novartis International Business Overview
Table 81. Novartis International Androgen Deprivation Therapy (ADT) Product
Table 82. Novartis International Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)
Table 83. Novartis International Recent Developments
Table 84. Merck Company Details
Table 85. Merck Business Overview
Table 86. Merck Androgen Deprivation Therapy (ADT) Product
Table 87. Merck Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)
Table 88. Merck Recent Developments
Table 89. Veru Company Details
Table 90. Veru Business Overview
Table 91. Veru Androgen Deprivation Therapy (ADT) Product
Table 92. Veru Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)
Table 93. Veru Recent Developments
Table 94. Sanofi Company Details
Table 95. Sanofi Business Overview
Table 96. Sanofi Androgen Deprivation Therapy (ADT) Product
Table 97. Sanofi Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)
Table 98. Sanofi Recent Developments
Table 99. GlaxoSmithKline Company Details
Table 100. GlaxoSmithKline Business Overview
Table 101. GlaxoSmithKline Androgen Deprivation Therapy (ADT) Product
Table 102. GlaxoSmithKline Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)
Table 103. GlaxoSmithKline Recent Developments
Table 104. Bayer Company Details
Table 105. Bayer Business Overview
Table 106. Bayer Androgen Deprivation Therapy (ADT) Product
Table 107. Bayer Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)
Table 108. Bayer Recent Developments
Table 109. Orion Company Details
Table 110. Orion Business Overview
Table 111. Orion Androgen Deprivation Therapy (ADT) Product
Table 112. Orion Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)
Table 113. Orion Recent Developments
Table 114. AstraZeneca Company Details
Table 115. AstraZeneca Business Overview
Table 116. AstraZeneca Androgen Deprivation Therapy (ADT) Product
Table 117. AstraZeneca Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)
Table 118. AstraZeneca Recent Developments
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Androgen Deprivation Therapy (ADT) Market Share by Type: 2023 VS 2030
Figure 3. Medicine Features
Figure 4. Surgery Features
Figure 5. Other Features
Figure 6. Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Androgen Deprivation Therapy (ADT) Market Share by Application: 2023 VS 2030
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Other Case Studies
Figure 11. Androgen Deprivation Therapy (ADT) Report Years Considered
Figure 12. Global Androgen Deprivation Therapy (ADT) Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Androgen Deprivation Therapy (ADT) Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Androgen Deprivation Therapy (ADT) Market Share by Region: 2023 VS 2030
Figure 15. Global Androgen Deprivation Therapy (ADT) Market Share by Players in 2023
Figure 16. Global Top Androgen Deprivation Therapy (ADT) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Androgen Deprivation Therapy (ADT) as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Androgen Deprivation Therapy (ADT) Revenue in 2023
Figure 18. North America Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Androgen Deprivation Therapy (ADT) Market Share by Type (2019-2030)
Figure 20. North America Androgen Deprivation Therapy (ADT) Market Share by Application (2019-2030)
Figure 21. North America Androgen Deprivation Therapy (ADT) Market Share by Country (2019-2030)
Figure 22. United States Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Androgen Deprivation Therapy (ADT) Market Size YoY (2019-2030) & (US$ Million)
Figure 25. Europe Androgen Deprivation Therapy (ADT) Market Share by Type (2019-2030)
Figure 26. Europe Androgen Deprivation Therapy (ADT) Market Share by Application (2019-2030)
Figure 27. Europe Androgen Deprivation Therapy (ADT) Market Share by Country (2019-2030)
Figure 28. Germany Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. China Androgen Deprivation Therapy (ADT) Market Size YoY (2019-2030) & (US$ Million)
Figure 35. China Androgen Deprivation Therapy (ADT) Market Share by Type (2019-2030)
Figure 36. China Androgen Deprivation Therapy (ADT) Market Share by Application (2019-2030)
Figure 37. Asia Androgen Deprivation Therapy (ADT) Market Size YoY (2019-2030) & (US$ Million)
Figure 38. Asia Androgen Deprivation Therapy (ADT) Market Share by Type (2019-2030)
Figure 39. Asia Androgen Deprivation Therapy (ADT) Market Share by Application (2019-2030)
Figure 40. Asia Androgen Deprivation Therapy (ADT) Market Share by Region (2019-2030)
Figure 41. Japan Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. South Korea Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. China Taiwan Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. India Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Australia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Size YoY (2019-2030) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Share by Type (2019-2030)
Figure 49. Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Share by Application (2019-2030)
Figure 50. Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Share by Country (2019-2030)
Figure 51. Brazil Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Mexico Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Turkey Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Israel Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. GCC Countries Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. Pfizer Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)
Figure 58. Astellas Pharma Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)
Figure 59. Johnson & Johnson Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)
Figure 60. Novartis International Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)
Figure 61. Merck Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)
Figure 62. Veru Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)
Figure 63. Sanofi Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)
Figure 64. GlaxoSmithKline Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)
Figure 65. Bayer Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)
Figure 66. Orion Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)
Figure 67. AstraZeneca Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Table 1. Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Medicine
Table 3. Key Players of Surgery
Table 4. Key Players of Other
Table 5. Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Androgen Deprivation Therapy (ADT) Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Androgen Deprivation Therapy (ADT) Market Share by Region (2019-2024)
Table 9. Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Androgen Deprivation Therapy (ADT) Market Share by Region (2025-2030)
Table 11. Androgen Deprivation Therapy (ADT) Market Trends
Table 12. Androgen Deprivation Therapy (ADT) Market Drivers
Table 13. Androgen Deprivation Therapy (ADT) Market Challenges
Table 14. Androgen Deprivation Therapy (ADT) Market Restraints
Table 15. Global Androgen Deprivation Therapy (ADT) Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Androgen Deprivation Therapy (ADT) Revenue Share by Players (2019-2024)
Table 17. Global Top Androgen Deprivation Therapy (ADT) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Androgen Deprivation Therapy (ADT) as of 2023)
Table 18. Global Androgen Deprivation Therapy (ADT) Industry Ranking 2022 VS 2023 VS 2024
Table 19. Global 5 Largest Players Market Share by Androgen Deprivation Therapy (ADT) Revenue (CR5 and HHI) & (2019-2024)
Table 20. Global Key Players of Androgen Deprivation Therapy (ADT), Headquarters and Area Served
Table 21. Global Key Players of Androgen Deprivation Therapy (ADT), Product and Application
Table 22. Global Key Players of Androgen Deprivation Therapy (ADT), Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Androgen Deprivation Therapy (ADT) Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Type (2019-2024)
Table 26. Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Type (2025-2030)
Table 28. Global Androgen Deprivation Therapy (ADT) Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Androgen Deprivation Therapy (ADT) Revenue Share by Application (2019-2024)
Table 30. Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Androgen Deprivation Therapy (ADT) Revenue Share by Application (2025-2030)
Table 32. North America Androgen Deprivation Therapy (ADT) Market Size by Type (2019-2024) & (US$ Million)
Table 33. North America Androgen Deprivation Therapy (ADT) Market Size by Type (2025-2030) & (US$ Million)
Table 34. North America Androgen Deprivation Therapy (ADT) Market Size by Application (2019-2024) & (US$ Million)
Table 35. North America Androgen Deprivation Therapy (ADT) Market Size by Application (2025-2030) & (US$ Million)
Table 36. North America Androgen Deprivation Therapy (ADT) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Androgen Deprivation Therapy (ADT) Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Androgen Deprivation Therapy (ADT) Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Androgen Deprivation Therapy (ADT) Market Size by Type (2019-2024) & (US$ Million)
Table 40. Europe Androgen Deprivation Therapy (ADT) Market Size by Type (2025-2030) & (US$ Million)
Table 41. Europe Androgen Deprivation Therapy (ADT) Market Size by Application (2019-2024) & (US$ Million)
Table 42. Europe Androgen Deprivation Therapy (ADT) Market Size by Application (2025-2030) & (US$ Million)
Table 43. Europe Androgen Deprivation Therapy (ADT) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2019-2024) & (US$ Million)
Table 45. Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2025-2030) & (US$ Million)
Table 46. China Androgen Deprivation Therapy (ADT) Market Size by Type (2019-2024) & (US$ Million)
Table 47. China Androgen Deprivation Therapy (ADT) Market Size by Type (2025-2030) & (US$ Million)
Table 48. China Androgen Deprivation Therapy (ADT) Market Size by Application (2019-2024) & (US$ Million)
Table 49. China Androgen Deprivation Therapy (ADT) Market Size by Application (2025-2030) & (US$ Million)
Table 50. Asia Androgen Deprivation Therapy (ADT) Market Size by Type (2019-2024) & (US$ Million)
Table 51. Asia Androgen Deprivation Therapy (ADT) Market Size by Type (2025-2030) & (US$ Million)
Table 52. Asia Androgen Deprivation Therapy (ADT) Market Size by Application (2019-2024) & (US$ Million)
Table 53. Asia Androgen Deprivation Therapy (ADT) Market Size by Application (2025-2030) & (US$ Million)
Table 54. Asia Androgen Deprivation Therapy (ADT) Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 55. Asia Androgen Deprivation Therapy (ADT) Market Size by Region (2019-2024) & (US$ Million)
Table 56. Asia Androgen Deprivation Therapy (ADT) Market Size by Region (2025-2030) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Size by Type (2019-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Size by Type (2025-2030) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Size by Application (2019-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Size by Application (2025-2030) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 62. Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2019-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2025-2030) & (US$ Million)
Table 64. Pfizer Company Details
Table 65. Pfizer Business Overview
Table 66. Pfizer Androgen Deprivation Therapy (ADT) Product
Table 67. Pfizer Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)
Table 68. Pfizer Recent Developments
Table 69. Astellas Pharma Company Details
Table 70. Astellas Pharma Business Overview
Table 71. Astellas Pharma Androgen Deprivation Therapy (ADT) Product
Table 72. Astellas Pharma Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)
Table 73. Astellas Pharma Recent Developments
Table 74. Johnson & Johnson Company Details
Table 75. Johnson & Johnson Business Overview
Table 76. Johnson & Johnson Androgen Deprivation Therapy (ADT) Product
Table 77. Johnson & Johnson Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)
Table 78. Johnson & Johnson Recent Developments
Table 79. Novartis International Company Details
Table 80. Novartis International Business Overview
Table 81. Novartis International Androgen Deprivation Therapy (ADT) Product
Table 82. Novartis International Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)
Table 83. Novartis International Recent Developments
Table 84. Merck Company Details
Table 85. Merck Business Overview
Table 86. Merck Androgen Deprivation Therapy (ADT) Product
Table 87. Merck Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)
Table 88. Merck Recent Developments
Table 89. Veru Company Details
Table 90. Veru Business Overview
Table 91. Veru Androgen Deprivation Therapy (ADT) Product
Table 92. Veru Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)
Table 93. Veru Recent Developments
Table 94. Sanofi Company Details
Table 95. Sanofi Business Overview
Table 96. Sanofi Androgen Deprivation Therapy (ADT) Product
Table 97. Sanofi Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)
Table 98. Sanofi Recent Developments
Table 99. GlaxoSmithKline Company Details
Table 100. GlaxoSmithKline Business Overview
Table 101. GlaxoSmithKline Androgen Deprivation Therapy (ADT) Product
Table 102. GlaxoSmithKline Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)
Table 103. GlaxoSmithKline Recent Developments
Table 104. Bayer Company Details
Table 105. Bayer Business Overview
Table 106. Bayer Androgen Deprivation Therapy (ADT) Product
Table 107. Bayer Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)
Table 108. Bayer Recent Developments
Table 109. Orion Company Details
Table 110. Orion Business Overview
Table 111. Orion Androgen Deprivation Therapy (ADT) Product
Table 112. Orion Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)
Table 113. Orion Recent Developments
Table 114. AstraZeneca Company Details
Table 115. AstraZeneca Business Overview
Table 116. AstraZeneca Androgen Deprivation Therapy (ADT) Product
Table 117. AstraZeneca Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)
Table 118. AstraZeneca Recent Developments
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Androgen Deprivation Therapy (ADT) Market Share by Type: 2023 VS 2030
Figure 3. Medicine Features
Figure 4. Surgery Features
Figure 5. Other Features
Figure 6. Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Androgen Deprivation Therapy (ADT) Market Share by Application: 2023 VS 2030
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Other Case Studies
Figure 11. Androgen Deprivation Therapy (ADT) Report Years Considered
Figure 12. Global Androgen Deprivation Therapy (ADT) Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Androgen Deprivation Therapy (ADT) Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Androgen Deprivation Therapy (ADT) Market Share by Region: 2023 VS 2030
Figure 15. Global Androgen Deprivation Therapy (ADT) Market Share by Players in 2023
Figure 16. Global Top Androgen Deprivation Therapy (ADT) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Androgen Deprivation Therapy (ADT) as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Androgen Deprivation Therapy (ADT) Revenue in 2023
Figure 18. North America Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Androgen Deprivation Therapy (ADT) Market Share by Type (2019-2030)
Figure 20. North America Androgen Deprivation Therapy (ADT) Market Share by Application (2019-2030)
Figure 21. North America Androgen Deprivation Therapy (ADT) Market Share by Country (2019-2030)
Figure 22. United States Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Androgen Deprivation Therapy (ADT) Market Size YoY (2019-2030) & (US$ Million)
Figure 25. Europe Androgen Deprivation Therapy (ADT) Market Share by Type (2019-2030)
Figure 26. Europe Androgen Deprivation Therapy (ADT) Market Share by Application (2019-2030)
Figure 27. Europe Androgen Deprivation Therapy (ADT) Market Share by Country (2019-2030)
Figure 28. Germany Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. China Androgen Deprivation Therapy (ADT) Market Size YoY (2019-2030) & (US$ Million)
Figure 35. China Androgen Deprivation Therapy (ADT) Market Share by Type (2019-2030)
Figure 36. China Androgen Deprivation Therapy (ADT) Market Share by Application (2019-2030)
Figure 37. Asia Androgen Deprivation Therapy (ADT) Market Size YoY (2019-2030) & (US$ Million)
Figure 38. Asia Androgen Deprivation Therapy (ADT) Market Share by Type (2019-2030)
Figure 39. Asia Androgen Deprivation Therapy (ADT) Market Share by Application (2019-2030)
Figure 40. Asia Androgen Deprivation Therapy (ADT) Market Share by Region (2019-2030)
Figure 41. Japan Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. South Korea Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. China Taiwan Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. India Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Australia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Size YoY (2019-2030) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Share by Type (2019-2030)
Figure 49. Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Share by Application (2019-2030)
Figure 50. Middle East, Africa, and Latin America Androgen Deprivation Therapy (ADT) Market Share by Country (2019-2030)
Figure 51. Brazil Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Mexico Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Turkey Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Israel Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. GCC Countries Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. Pfizer Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)
Figure 58. Astellas Pharma Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)
Figure 59. Johnson & Johnson Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)
Figure 60. Novartis International Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)
Figure 61. Merck Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)
Figure 62. Veru Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)
Figure 63. Sanofi Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)
Figure 64. GlaxoSmithKline Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)
Figure 65. Bayer Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)
Figure 66. Orion Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)
Figure 67. AstraZeneca Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232